Pharvaris holder plans $7M sale of 200K shares

A Pharvaris N.V. shareholder filed a Rule 144 notice to sell 200,000 common shares valued at $7 million, following earlier sales in recent months.

Available on EDGAR 09/17/2026 - 05:28 PM EDT Accepted by SEC EDGAR 09/17/2026 - 05:27 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is the issuer for which shareholder Johannes Gerardus Christiaan Petrus Schikan has filed a notice of proposed sale of restricted or control securities under Rule 144. The filing lists a planned sale of 200,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $7,000,000.00, and discloses several prior common-share sales in the past three months.

Key Figures

Planned shares to be sold: 200,000 shares Aggregate market value of planned sale: $7,000,000.00 Shares sold on June 30, 2026: 30,172 shares +5 more

8 metrics

Planned shares to be sold 200,000 shares Common stock proposed for sale under Rule 144

Aggregate market value of planned sale $7,000,000.00 Estimated value for 200,000 Pharvaris N.V. common shares

Shares sold on June 30, 2026 30,172 shares Common stock sale during the past three months

Total proceeds June 30, 2026 sale $1,089,968.80 Proceeds from 30,172 Pharvaris N.V. common shares sold

Shares sold on June 29, 2026 (first transaction) 6,888 shares Common stock sale during the past three months

Total proceeds June 29, 2026 (6,888 shares) $241,424.40 Proceeds from 6,888 Pharvaris N.V. common shares sold

Shares sold on June 29, 2026 (second transaction) 2,400 shares Additional common stock sale during the past three months

Total proceeds June 29, 2026 (2,400 shares) $84,240.00 Proceeds from 2,400 Pharvaris N.V. common shares sold

Key Terms

Rule 144, Founder Stock, aggregate market value, Securities To Be Sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founder Stock financial

"Common | 12/23/2015 | Founder Stock | Issuer"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 200000 | 7000000.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for PHVS disclose about planned share sales?

The notice states that Johannes Gerardus Christiaan Petrus Schikan plans to sell 200,000 Pharvaris N.V. common shares under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value listed as $7,000,000.00.

Who is the selling security holder in the PHVS Form 144 filing?

The selling security holder is Johannes Gerardus Christiaan Petrus Schikan, for whose account Pharvaris N.V. common shares are to be sold pursuant to Rule 144.

How many PHVS shares has the filer sold in the past three months?

The filing reports three past sales of Pharvaris N.V. common stock: 30,172 shares on June 30, 2026, 6,888 shares on June 29, 2026, and 2,400 shares on June 29, 2026, with corresponding total sale proceeds listed for each transaction.

What type of PHVS securities are covered in this Form 144?

The Form 144 covers common stock of Pharvaris N.V., including 200,000 shares of founder stock that are proposed to be sold and prior sales of common shares disclosed for the past three months.

Through which broker are the planned PHVS share sales to be executed?

The planned sale of 200,000 Pharvaris N.V. common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

When were the PHVS founder shares originally acquired according to the filing?

The filing shows that the 200,000 Pharvaris N.V. founder stock shares to be sold were originally acquired on December 23, 2015 from the issuer for cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014983
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	JOHANNES GER. CHRIS. PE SCHIKAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	200000	7000000.00	65210590	09/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/23/2015	Founder Stock	Issuer			200000	12/23/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/30/2026	30172	1089968.80
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	6888	241424.40
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	2400	84240.00

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johannes Gerardus Christiaan Petrus Schikan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)